Urinalysis Market

Global Urinalysis Market Size (2023 to 2028)

The global market size for urinalysis is estimated to be growing at a CAGR of 6.68% from 2023 to 2028 and will be worth USD 5.79 billion by 2028 from USD 4.19 billion in 2023.

Urinalysis is a urine sample analysis test that aids in the detection of a wide range of illnesses, including diabetes, kidney disease, and urinary tract infection. Its primary objective is to monitor people's health. Urinalysis is done as part of a regular medical check-up, pre-surgery preparation, pregnancy testing, or as part of hospital admission to treat a range of conditions.

Impact of COVID-19 on the global urinalysis market:

COVID-19 is an infectious disease-causing coronavirus that has only recently been discovered. COVID-19, which was primarily unknown until its emergence in Wuhan, China, in December 2019, went from a regional problem to a global pandemic in a matter of weeks. Most companies' total revenues suffered as a result of the COVID-19 outbreak. People put off getting their health checked because of the COVID-19 outbreak, which reduced the number of tests performed and reagent sales. COVID-19 participants who had an AKI or ARF (acute renal failure) were advised to frequently consult a kidney doctor since their risk of acquiring chronic kidney disease was higher. During the COVID-19 pandemic, the urinalysis sector continued to see a tremendous acceleration in the market's growth rate. During the forecast period, the increased risk of COVID-19 infection among individuals with a history of chronic kidney disease (CKD) led to a rise in the demand for routine urinalysis.

MARKET DRIVERS:

The growing aging population in developed and emerging countries is one of the significant factors promoting the growth rate of the global urinalysis market.

As the senior population grows, the prevalence of age-related illnesses such as diabetes, liver disease, and renal disease is expected to rise significantly. The rising frequency of prescriptions for tests like creatinine, albumin, glucose, ketones, and bilirubin, among others, is due to the diagnosis and therapy of such conditions. Urinalysis is used to do these tests; hence, it is likely to impact the market positively. Furthermore, integrated urinalysis systems would give considerable growth prospects for various market players, allowing them to tap into a more extensive consumer base.

The number of tests will be driven by the need to protect the safety and health of women throughout pregnancy. Furthermore, changes in hormone levels during pregnancy raise the risk of urinary tract infection in women who are more likely to have kidney impairment. Premature birth, high blood pressure, low birth weight, and severe preeclampsia are among the serious pregnancy problems caused by UTIs. As a result, healthcare professionals' preferences and recommendations for urine testing during pregnancy will propel the urinalysis market forward in the future years. It also aids in determining the root of symptoms, including back pain, abdominal pain, and uncomfortable urination. The market has a vast pool of potential growth opportunities due to the large base of the target population and the identified high, unmet clinical needs in underdeveloped regions. To take advantage of these opportunities, diagnostic technologies must be developed to address these unmet clinical demands at a reasonable cost.

MARKET RESTRAINTS:

The expansion of the global urinalysis market is expected to be hampered by the high cost of urinalysis equipment and stringent regulatory standards. The availability of refurbished instruments, which provide the same functionality as new equipment at a reduced price, poses a challenge to the market's growth.

REPORT COVERAGE:

This research report on the global urinalysis market has been segmented and sub-segmented based on type, application, end-user, and region.

Global Urinalysis Market Analysis – By Product:

• Consumables
  • Dipsticks
  • Reagents
  • Disposables
• Instruments
  • Biochemical Urine Analyzer
  • Automated Urine Sediment Analyzer

Based on the product, the consumables segment had the largest share in the global urinalysis market in 2022. Because more doctors recommend regular urine tests, the demand for consumables has soared. In addition, consumables such as reagent strips can quickly identify infection, fat breakdown, and diabetes. Increased public awareness is one of the notable factors fueling the demand for consumable products. In addition, increased advances in various urine test strips and test kits and the rising need for user-friendly, low-cost dipsticks and consumables are estimated to drive the growth of the urinalysis market.

Global Urinalysis Market Analysis – By Application:

• Disease Screening
  • Urinary Tract Infections
  • Kidney Diseases
  • Diabetes
  • Liver Diseases
  • Other Disease Screening Applications
• Pregnancy and Fertility

In 2022, the disease screening application dominated the global urinalysis market. The growing need for early detection of various diseases, the rising prevalence of chronic diseases such as diabetes, the aging population, and increased awareness of the importance of regular health check-ups are major drivers driving this segment's growth.

Global Urinalysis Market Analysis – By End-User:

• Clinical Laboratories
• Hospitals
• Home Healthcare

In 2022, the clinical laboratories segment had the highest share in the global urinalysis market, and it is expected to grow at a significant rate throughout the forecast period. Clinical laboratories are expected to witness a higher volume of urinalysis due to the benefits they provide in deciding a course of action or therapy for a patient. This will help the market grow. Furthermore, qualified administrators and specialists in settings will lead to a preference for clinical laboratories among customers.

Global Urinalysis Market Analysis – By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Geographically, Asia Pacific is expected to increase at the quickest rate during the forecast period; due to factors such as increasing incidences of kidney diseases, urinary tract infections, and diabetes, technological advancements; awareness about urinalysis tests in the region; and a large number of emerging local players, China is expected to grow at the fastest CAGR during the forecast period in this region. Furthermore, over the forecast period, the increasing penetration rate of advanced urine analyzers, local urine analyzer manufacturers such as Mindray and Urit Medical, and a massive base of the target population with unmet clinical needs are projected to fuel market expansion.

On the other hand, Europe is expected to have the second-largest share of the global urinalysis market during the forecast period, owing to the rising prevalence of urinary tract infections and increased government programs to improve public awareness of urinalysis. As a result, Germany dominated the European urinalysis market, which is likely to continue during the forecast period.

In 2022, North America led the global urinalysis market, and the dominance is expected to be continuing throughout the forecast period. The growing elderly population, implementation of favorable government programs, increased healthcare expenditure, and improved healthcare infrastructure is expected to contribute to the growth of the North American urinalysis market. The United States generated the most income in North American and worldwide urinalysis markets. The presence of a massive pool of patients having pregnancy tests and widespread acceptance of point-of-care diagnostic instruments is the primary growth driver for the urinalysis market in the United States.

KEY MARKET PARTICIPANTS:

Arkray Inc., Beckman Coulter Inc., Roche Diagnostics, Siemens Healthcare, Sysmex Corporation, Elektronika KFT, Acon Laboratories Inc., and Bio-Rad Laboratories Inc. are promising companies in the global urinalysis market profiled in this report.

RECENT HAPPENINGS IN THIS MARKET:

• Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostics products, announced the release of Quantify Advance Control for use in clinical labs doing urinalysis testing in 2019.
• Sysmex America Signs Exclusive Agreement with Siemens Healthineers to Distribute and Service Automated Urine Chemistry Analyzer in 2020
• At the AACC Annual Scientific Meeting & Clinical Lab Expo in 2021, Beckman Coulter announced the debut of its DxU Iris Workcell. The DxU Iris Workcell is a fully automated urinalysis workflow solution that eliminates 4 percent of manual evaluations.